Breast cancer is composed of a number of defined molecular subtypes delineated by the expression/absence of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.